Responses
Immune cell therapies and immune cell engineering
Original research
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
